TBPH icon

Theravance Biopharma

115 hedge funds and large institutions have $655M invested in Theravance Biopharma in 2021 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 49 increasing their positions, 28 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$978K
Puts
$4.14M
Net Calls
Net Calls Change

Top Buyers

1 +$28.8M
2 +$19M
3 +$10.5M
4
NM
Newtyn Management
New York
+$9.97M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$5.04M

Top Sellers

1 -$36M
2 -$22.1M
3 -$15.5M
4
Millennium Management
Millennium Management
New York
-$10.2M
5
C
Chescapmanager
Maryland
-$6.97M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$151M
2
$73.5M
3
$69.6M
4
$66M
5
$55.3M
6
$28.8M
7
$28.6M
8
$16.3M
9
$15M
10
$13.9M
11
$11.5M
12
$11.3M
13
$11.1M
14
$9.68M
15
$7.25M
16
$6.79M
17
$6.36M
18
$5.89M
19
$5.53M
20
$4.32M
21
$3.8M
22
$2.87M
23
$2.75M
24
$2.37M
25
$2.27M